大鼠脊髓损伤后MicroRNAs表达谱变化

目的:探究大鼠脊髓损伤后microRNAs表达谱变化。方法:将10只成年SD大鼠随机分为假手术组、模型组,建立脊髓损伤模型。术后采用Basso-Beattie-Bresnahan(BBB)量表进行运动功能评分,苏木精-伊红(HE)染色脊髓组织,通过Illumina高通量测序技术,对前期构建的cDNA文库进行RNA-Seq分析。将测序数据与高粱参考基因组对比后,以P<0.05为条件筛选出差异表达基因,通过GO、KEGG等数据库,对DEGs的功能以及参与的调控路径进行分析,并通过RT-qPCR验证RNA-Seq结果的可靠性。结果:假手术组与模型组BBB评分有显著性差异,HE染色观察到脊髓组织结构受损较为严重,脊髓损伤前后microRNAs表达有显著差异。结论:脊髓损伤许多基因表达失调。

筛选的差异表达microRNAs对猪卵母细胞Npm2基因的表达调控及作用研究

旨在研究卵母细胞中筛选的差异表达microRNAs对Npm2(nucleoplasmin 2)基因的调控作用。本研究采集屠宰场卵巢,收集GV期卵母细胞进行体外成熟培养,收集MⅡ期卵母细胞。使用qPCR检测筛选的差异表达miRNAs在GV、MⅡ期卵母细胞的表达水平;双荧光素酶报告试验验证预测的miRNA是否与靶基因Npm2存在结合位点;在体外成熟培养液中添加miRNAs模拟物/抑制物,验证miRNA对卵母细胞体外成熟和孤雌胚胎体外发育能力的影响。添加最适浓度的miRNAs模拟物/抑制物后,使用花生凝集素染色试验检测皮质颗粒分布和qPCR检测Npm2 mRNA表达水平。结果表明,MⅡ期卵母细胞中miR-150、miR-7138-5p表达显著高于GV期卵母细胞(P<0.05),miR-296-3p、miR-423-3p表达水平极显著低于GV期卵母细胞(P<0.01),表达趋势与测序结果一致。miR-32表达水平无显著差异(P>0.05)。双荧光素酶报告试验结果表明,miR-32、miR-7138-5p、miR-296-3p与Npm2存在结合位点,荧光强度极显著下调(P<0.01);miR-150与Npm2存在结合位点,荧光强度显著下调(P<0.05);miR-296-5p、miR-423-3p与Npm2不存在结合位点,荧光强度无显著变化(P>0.05)。通过在体外成熟培养液中添加不同浓度miRNAs模拟物/抑制物以确定最适浓度,添加miR-32抑制物、miR-296-5p模拟物、miR-296-5p抑制物、miR-423-3p模拟物、miR-423-3p抑制物、miR-7138抑制物、miR-150模拟物、miR-150抑制物后皮质颗粒荧光强度极显著下调(P<0.01);添加miR-296-3p抑制物、miR-7138-5p模拟物后皮质颗粒荧光强度显著下调(P<0.05)。MⅡ期卵母细胞Npm2 mRNA表达量极显著高于GV期卵母细胞,添加最适浓度miR-150、miR-296-3p、miR-296-5p、miR-7138-5p模拟物和/或抑制物Npm2 mRNA表达量与对照组有显著差异(P<0.05),添加miR-32、miR-423-3p模拟物/抑制物后MⅡ期卵母细胞Npm2 mRNA表达量与对照组无显著差异(P>0.05)。筛选的差异miRNA(如miR-296-3p、miR-7138-5p)可能通过调控Npm2表达影响卵母细胞体外成熟及早期胚胎体外发育,可为猪卵母细胞microRNAs与靶基因复杂调控网络研究提供基础。

靶向严重急性呼吸系统综合症冠状病毒2的人工microRNAs设计与思考

动植物人工miRNAs(artificial miRNAs,amiRNAs)在抗病毒感染中发挥重要作用。然而,有关amiRNAs靶向抑制重症急性呼吸综合征冠状病毒2(severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)的相关研究未见报道。目的:本研究旨在设计靶向SARS-CoV-2的amiRNAs,进一步分析amiRNAs对不同变异株的匹配程度。方法:利用Invitrogen Block-iT RNAi Designer成功设计靶向SARS-CoV-2的amiRNAs。结果:分别命名为amiR-Cov23utr-1、2、3、4;其中amiR-Cov23utr-1、3和4在Omicron BA.5/2022中靶向区域序列十分保守;amiR-Cov23utr-2在Omicron BA.5/2022中的靶点缺失。结论:本研初步设计和分析了靶向SARS-CoV-2的amiRNAs,为后续深入研究amiRNAs抗SARS-CoV-2感染提供了重要基础资料。

MicroRNAs as potential biomarkers for diagnosis of schizophrenia and influence of antipsychotic treatment

Chara cterized by positive symptoms(such as changes in behavior or thoughts,including delusions and hallu cinations),negative symptoms(such as apathy,anhedonia,and social withdrawal),and cognitive impairments,schizophrenia is a chro nic,severe,and disabling mental disorder with late adolescence or early adulthood onset,Antipsychotics are the most commonly used drugs to treat schizophrenia,but those currently in use do not fully reverse all three types of symptoms characte rizing this condition.Schizophrenia is frequently misdiagnosed,resulting in a delay of or inappropriate treatment.Abnormal expression of microRNAs is connected to brain development and disease and could provide novel biomarkers for the diagnosis and prognosis of schizophrenia.The recent studies reviewed included microRNA profiling in blood-and urine-based materials and nervous tissue mate rials.From the studies that had validated the preliminary findings,potential candidate biomarkers for schizophrenia in adults could be miR-22-3p,-30e-5p,-92a-3p,-148b-5p,-181a-3p,-181a-5p,-181b-5p,-199 b-5p,-137 in whole blood,and miR-130b,-193a-3p in blood plasma.Antipsychotic treatment of schizophrenia patients was found to modulate the expression of certain microRNAs including miR-130b,-193a-3p,-132,-195,-30e,-432 in blood plasma.Further studies are warranted with adolescents and young adults having schizophrenia and consideration should be given to using animal models of the disorder to investigate the effect of suppressing or overexpressing specific microRNAs.

microRNAs在骨质疏松症发生发展中的研究进展

骨质疏松的发生是由于成骨细胞介导的骨形成和破骨细胞介导的骨吸收平衡被打破,而使骨稳态出现异常。骨稳态调节因子microRNAs作为表观调控因子,通过调控成骨细胞和破骨细胞的相关信号分子的表达,使其在骨代谢中发挥重要作用。本文就microRNAs在骨质疏松症中参与调节维持骨微环境的细胞分化、增殖、自噬和在相关信号分子、相关信号通路的表达等方面最新研究进展进行综述,并总结了microRNAs在骨细胞分化中的作用,突出了microRNAs在代谢性骨疾病中作为治疗靶点的潜力。

Potential clinical application of microRNAs in bladder cancer

Bladder cancer(BC)is the tenth most prevalent malignancy globally,presenting significant clinical and societal challenges because of its high incidence,rapid progression,and frequent recurrence.Presently,cystoscopy and urine cytology serve as the established diagnostic methods for BC.However,their efficacy is limited by their invasive nature and low sensitivity.Therefore,the development of highly specific biomarkers and effective noninvasive detection strategies is imperative for achieving a precise and timely diagnosis of BC,as well as for facilitating an optimal tumor treatment and an improved prognosis.microRNAs(miRNAs),short noncoding RNA molecules spanning around 20–25 nucleotides,are implicated in the regulation of diverse carcinogenic pathways.Substantially altered miRNAs form robust functional regulatory networks that exert a notable influence on the tumorigenesis and progression of BC.Investigations into aberrant miRNAs derived from blood,urine,or extracellular vesicles indicate their potential roles as diagnostic biomarkers and prognostic indicators in BC,enabling miRNAs to monitor the progression and predict the recurrence of the disease.Simultaneously,the investigation centered on miRNA as a potential therapeutic agent presents a novel approach for the treatment of BC.This review comprehensively analyzes biological roles of miRNAs in tumorigenesis and progression,and systematically summarizes their potential as diagnostic and prognostic biomarkers,as well as therapeutic targets for BC.Additionally,we evaluate the progress made in laboratory techniques within this field and discuss the prospects.

Exosomal microRNAs in hepatocellular carcinoma,expanding research field

In this editorial we comment on the review by Wang et al published in the recent issue of the World Journal of Gastroenterology in 2023.Small extracellular vesicles(exosomes)play important roles in the tumor microenvironment.In this review,the authors introduce the following points:(1)The composition and function of exosomal microRNAs(miRNAs)of different cell origins in hepatocellular carcinoma(HCC);(2)the crosstalk between exosomal miRNAs from stromal cells and immune cells in the tumor microenvironment and the progression of HCC;and(3)the potential applicability of exosomal miRNAs derived from mesenchymal stem cells in the treatment of HCC.In addition,the potential applicability of exosomal miRNAs derived from mesenchymal stem cells in the treatment of HCC was introduced.In this review,the authors give us an overview of the exosomal RNA and summarize the function of exosomal RNA in HCC,which provides a deeper understanding of exosomal miRNAs to the readers.

MicroRNAs in hepatocellular carcinoma treatment:Charting the path forward

MicroRNAs(miRNAs)are recognized for their involvement in the regulation of gene expression and exhibit significant potential in both the prognostic assessment and treatment of hepatocellular carcinoma(HCC).HCC,like other tumors,seldom occurs in isolation;instead,it evolves within a microenvironment featuring oncogenic and tumor-suppressive elements.When combined with suitable delivery vehicles,miRNA technology provides the capability to directly engage with these elements,thereby hindering tumor formation and progression.Ongoing research in this domain holds the promise of enabling a more efficacious and multi-modal treatment approach for HCC in the near future.

microRNAs在帕金森病发病机制中作用研究进展

帕金森病(Parkinson’s disease)发病机制复杂,多种机制已被证明与帕金森病的病理生理机制有关,如α-突触核蛋白的积累、氧化应激、异常细胞凋亡和神经炎症等。微小RNA(MicroRNA,miRNA)是一种由内源性基因编码的非编码单链RNA分子。在过去的十年里,许多研究报道了miRNA在一系列重要的生命过程中发挥作用。此外,大量的动物模型实验和临床研究也发现了miRNA在帕金森病中的失调,并证明miRNA通过不同的途径在帕金森病的发生发展中发挥了重要作用。本文综述了一些参与帕金森病发生发展的重要miRNAs。

MicroRNAs在妇科肿瘤发生发展中的研究进展

microRNAs(miRNAs)是一类小RNA分子,在植物和动物的基因表达调控中发挥着重要作用,miRNAs不参与蛋白质的直接合成,而是转录后基因表达的重要调控因子。它们不仅在身体发育中起着关键作用,也是细胞周期、凋亡和分化的关键调节因子。成熟miRNAs的产生需要几个关键步骤。首先,在细胞核中经由RNA polymerase II(PolII)转录完成聚腺苷酸化和封顶产生primary mi RNAs(Pri-miRNAs)。Pri-miRNAs通过Drosha/DGCR8复合物进一步加工合成hairpin precursor mi RNAs(pre-miRNAs)。Pre-miRNAs通过输出蛋白5(XPO5)输出到细胞质中,并被Dicer切割,在这一过程进行末端环的切割后形成成熟的miRNAs。miRNAs以互补序列结合靶mRNA,发挥调控作用。研究表明,超过30%的蛋白质编码基因受miRNAs调控。miRNAs的失调和功能障碍与人类疾病有关,miRNAs的异常表达被认为是癌症发生的重要过程。本文就microRNAs在妇科肿瘤发生发展中的研究现状进行综述。

microRNAs对脑出血后神经炎症影响的研究进展

脑出血后所释放的大量内源性物质和血液中的毒性成分可加剧炎性反应和神经缺损,严重影响脑出血患者预后。microRNAs水平在脑出血后发生变化,可通过多种机制调控神经炎症的功能。文章综述归纳总结了microRNAs对脑出血后神经炎症影响的研究进展,旨在为出血性中风患者发现更有效的治疗方法。A large number of endogenous substances and toxic components in blood released after intracerebral hemorrhage can aggravate inflammatory reaction and neurological damage, which seriously affect the prognosis of patients with intracerebral hemorrhage. The level of microRNAs changes after intracerebral hemorrhage, which can regulate the function of neuroinflammation through various mechanisms. This review summarizes the research progress of the effect of microRNAs on neuroinflammation after intracerebral hemorrhage in order to find more effective treatment methods for patients with hemorrhagic stroke.

microRNAs调节MAPK信号通路防治骨质疏松症研究进展

骨质疏松症是一种常见的、发病以中老年人群为主的代谢性疾病。随着中国人口老龄化趋势不断加剧,探究骨质疏松症的生理病理进展对防治骨质疏松症及相关并发症的产生具有重大意义。microRNAs作为一种调节因子参与多种骨细胞的代谢调节,在与骨质疏松症密切相关的成骨细胞与破骨细胞分化与生成中起着关键因素,被认为是防治骨质疏松症的重要因子。MAPK信号通路作为与骨质疏松症相关的经典信号通路,对延缓骨质疏松症的进展具有重要的作用。研究表明,药物对microRNAs的调节能够起到防治骨质疏松症的作用,并与MAPK信号通路间存在联系。本文基于以上背景,探讨microRNAs与MAPK信号通路之间的相关性,并与骨质疏松症治疗中密切相关的骨细胞相联系,以期为骨质疏松症的治疗和预防提供更多的理论基础。

Acquired sensorineural hearing loss,oxidative stress,and microRNAs

Hearing loss is the third leading cause of human disability.Age-related hearing loss,one type of acquired sensorineural hearing loss,is largely responsible for this escalating global health burden.Noise-induced,ototoxic,and idiopathic sudden sensorineural are other less common types of acquired hearing loss.The etiology of these conditions is complex and multi-fa ctorial involving an interplay of genetic and environmental factors.Oxidative stress has recently been proposed as a likely linking cause in most types of acquired sensorineural hearing loss.Short non-coding RNA sequences known as microRNAs(miRNAs)have increasingly been shown to play a role in cellular hypoxia and oxidative stress responses including promoting an apoptotic response.Sensory hair cell death is a central histopathological finding in sensorineural hearing loss.As these cells do not regenerate in humans,it underlies the irreversibility of human age-related hearing loss.Ovid EMBASE,Ovid MEDLINE,Web of Science Core Collection,and ClinicalTrials.gov databases over the period August 1,2018 to July 31,2023 were searched with"hearing loss,""hypoxamiRs,""hypoxia,""microRNAs,""ischemia,"and"oxidative stress"text words for English language primary study publications or registered clinical trials.Registe red clinical trials known to the senior author we re also assessed.A total of 222studies were thus identified.After excluding duplicates,editorials,retra ctions,secondary research studies,and non-English language articles,39 primary studies and clinical trials underwent full-text screening.This resulted in 11 animal,in vitro,and/or human subject journal articles and 8 registered clinical trial database entries which form the basis of this narrative review.MiRNAs miR-34a and miR-29b levels increase with age in mice.These miRNAs were demonstrated in human neuroblastoma and murine cochlear cell lines to target Sirtuin 1/peroxisome proliferato r-activated receptor gamma coactivator-1-alpha(SIRT1/P GC-1α),SIRT1p53,and SIRT1/hypoxia-inducible factor 1-alpha signaling pathways resulting in increased apoptosis.Furthermore,hypoxia and oxidative stress had a similar adve rse apoptotic effect,which was inhibited by resve ratrol and a myocardial inhibitorassociated transcript,a miR-29b competing endogenous mRNA.Gentamicin reduced miR-182-5p levels and increased cochlear oxidative stress and cell death in mice-an effect that was corrected by inner ear stem cell-derived exosomes.There is ongoing work seeking to determine if these findings can be effectively translated to humans.

MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma:potential therapeutic targets and diagnostic/prognostic markers and web based tools

This review aimed to describe the inculpation of microRNAs(miRNAs)in thyroid cancer(TC)and its subtypes,mainly medullary thyroid carcinoma(MTC),and to outline web-based tools and databases for bioinformatics analysis of miRNAs in TC.Additionally,the capacity of miRNAs to serve as therapeutic targets and biomarkers in TC management will be discussed.This review is based on a literature search of relevant articles on the role of miRNAs in TC and its subtypes,mainly MTC.Additionally,web-based tools and databases for bioinformatics analysis of miRNAs in TC were identified and described.MiRNAs can perform as oncomiRs or antioncoges,relying on the target mRNAs they regulate.MiRNA replacement therapy using miRNA mimics or antimiRs that aim to suppress the function of certain miRNAs can be applied to correct miRNAs aberrantly expressed in diseases,particularly in cancer.MiRNAs are involved in the modulation of fundamental pathways related to cancer,resembling cell cycle checkpoints and DNA repair pathways.MiRNAs are also rather stable and can reliably be detected in different types of biological materials,rendering them favorable diagnosis and prognosis biomarkers as well.MiRNAs have emerged as promising tools for evaluating medical outcomes in TC and as possible therapeutic targets.The contribution of miRNAs in thyroid cancer,particularly MTC,is an active area of research,and the utility of web applications and databases for the biological data analysis of miRNAs in TC is becoming increasingly important.

MicroRNAs in inflammatory bowel disease:What do we know and what can we expect?

MicroRNAs(miRNAs),small non-coding RNAs composed of 18–24 nucleotides,are potent regulators of gene expression,contributing to the regulation of more than 30%of protein-coding genes.Considering that miRNAs are regulators of inflammatory pathways and the differentiation of intestinal epithelial cells,there is an interest in exploring their importance in inflammatory bowel disease(IBD).IBD is a chronic and multifactorial disease of the gastrointestinal tract;the main forms are Crohn's disease and ulcerative colitis.Several studies have investigated the dysregulated expression of miRNAs in IBD,demonstrating their important roles as regulators and potential biomarkers of this disease.This editorial presents what is known and what is expected regarding miRNAs in IBD.Although the important regulatory roles of miRNAs in IBD are clearly established,biomarkers for IBD that can be applied in clinical practice are lacking,emphasizing the importance of further studies.Discoveries regarding the influence of miRNAs on the inflammatory process and the exploration of their role in gene regulation are expected to provide a basis for the use of miRNAs not only as potent biomarkers in IBD but also as therapeutic targets for the control of inflammatory processes in personalized medicine.

MicroRNAs:A novel signature in the metastasis of esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma(ESCC)is a malignant epithelial tumor,characterized by squamous cell differentiation,it is the sixth leading cause of cancer-related deaths globally.The increased mortality rate of ESCC patients is predominantly due to the advanced stage of the disease when discovered,coupled with higher risk of metastasis,which is an exceedingly malignant charac-teristic of cancer,frequently leading to a high mortality rate.Unfortunately,there is currently no specific and effective marker to predict and treat metastasis in ESCC.MicroRNAs(miRNAs)are a class of small non-coding RNA molecules,approximately 22 nucleotides in length.miRNAs are vital in modulating gene expression and serve pivotal regulatory roles in the occurrence,progression,and prognosis of cancer.Here,we have examined the literature to highlight the intimate correlations between miRNAs and ESCC metastasis,and show that ESCC metastasis is predominantly regulated or regulated by genetic and epigenetic factors.This review proposes a potential role for miRNAs as diagnostic and therapeutic biomarkers for metastasis in ESCC metastasis,with the ultimate aim of reducing the mortality rate among patients with ESCC.

Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo

Exosomes,the smallest extracellular vesicles,have gained significant attention as key mediators in intercellular communication,influencing both physiological and pathological processes,particularly in cancer progression.A recent review article by Wang et al was published in a timely manner to stimulate future research and facilitate practical developments for targeted treatment of hepatocellular carcinoma using exosomes,with a focus on the origin from which exosomes derive.If information about the mechanisms for delivering exosomes to specific cells is incorporated,the concept of targeted therapy for hepatocellular carcinoma using exosomes could be more comprehensively understood.

MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder

Inappropriate levels of hyperactivity,impulsivity,and inattention characterize attention deficit hyperactivity disorder,a common childhood-onset neuropsychiatric disorder.The cognitive function and learning ability of children with attention deficit hyperactivity disorder are affected,and these symptoms may persist to adulthood if they are not treated.The diagnosis of attention deficit hyperactivity disorder is only based on symptoms and objective tests for attention deficit hyperactivity disorder are missing.Treatments for attention deficit hyperactivity disorder in children include medications,behavior therapy,counseling,and education services which can relieve many of the symptoms of attention deficit hyperactivity disorder but cannot cure it.There is a need for a molecular biomarker to distinguish attention deficit hyperactivity disorder from healthy subjects and other neurological conditions,which would allow for an earlier and more accurate diagnosis and appropriate treatment to be initiated.Abnormal expression of microRNAs is connected to brain development and disease and could provide novel biomarkers for the diagnosis and prognosis of attention deficit hyperactivity disorder.The recent studies reviewed had performed microRNA profiling in whole blood,white blood cells,blood plasma,and blood serum of children with attention deficit hyperactivity disorder.A large number of microRNAs were dysregulated when compared to healthy controls and with some overlap between individual studies.From the studies that had included a validation set of patients and controls,potential candidate biomarkers for attention deficit hyperactivity disorder in children could be miR-140-3p,let-7g-5p,-30e-5p,-223-3p,-142-5p,-486-5p,-151a-3p,-151a-5p,and-126-5p in total white blood cells,and miR-4516,-6090,-4763-3p,-4281,-4466,-101-3p,-130a-3p,-138-5p,-195-5p,and-106b-5p in blood serum.Further studies are warranted with children and adults with attention deficit hyperactivity disorder,and consideration should be given to utilizing rat models of attention deficit hyperactivity disorder.Animal studies could be used to confirm microRNA findings in human patients and to test the effects of targeting specific microRNAs on disease progression and behavior.

microRNAs对心脏电生理特性影响的研究进展

非心脏外科围术期心律失常的发生率4%~20%,而心胸外科围术期心律失常的发生率为10%~30%,其中心脏手术患者围术期心律失常的发生率高达90%。围术期心律失常可延长住院时间,增加患者住院期间的发病率和死亡率。研究表明,心血管疾病中存在的异常表达microRNAs可通过调控离子通道、缝隙连接蛋白及细胞内Ca2+处理蛋白等,参与心脏自律性、兴奋性以及传导性,从而调节心脏电生理稳态和心律失常。本文将主要从心脏电生理失衡的角度综述microRNA与心律失常的研究进展。

MicroRNAs as potential biomarkers for diagnosis of post-traumatic stress disorder

Post-traumatic stress disorder is a mental disorder caused by exposure to severe traumatic life events.Currently,there are no validated biomarkers or laboratory tests that can distinguish between trauma survivors with and without post-traumatic stress disorder.In addition,the heterogeneity of clinical presentations of post-traumatic stress disorder and the overlap of symptoms with other conditions can lead to misdiagnosis and inappropriate treatment.Evidence suggests that this condition is a multisystem disorder that affects many biological systems,raising the possibility that peripheral markers of disease may be used to diagnose post-traumatic stress disorder.We performed a PubMed search for microRNAs(miRNAs)in post-traumatic stress disorder(PTSD)that could serve as diagnostic biomarkers and found 18 original research articles on studies performed with human patients and published January 2012 to December 2023.These included four studies with whole blood,seven with peripheral blood mononuclear cells,four with plasma extracellular vesicles/exosomes,and one with serum exosomes.One of these studies had also used whole plasma.Two studies were excluded as they did not involve microRNA biomarkers.Most of the studies had collected samples from adult male Veterans who had returned from deployment and been exposed to combat,and only two were from recently traumatized adult subjects.In measuring miRNA expression levels,many of the studies had used microarray miRNA analysis,miRNA Seq analysis,or NanoString panels.Only six studies had used real time polymerase chain reaction assay to determine/validate miRNA expression in PTSD subjects compared to controls.The miRNAs that were found/validated in these studies may be considered as potential candidate biomarkers for PTSD and include miR-3130-5p in whole blood;miR-193a-5p,-7113-5p,-125a,-181c,and-671-5p in peripheral blood mononuclear cells;miR-10b-5p,-203a-3p,-4488,-502-3p,-874-3p,-5100,and-7641 in plasma extracellular vesicles/exosomes;and miR-18a-3p and-7-1-5p in blood plasma.Several important limitations identified in the studies need to be taken into account in future studies.Further studies are warranted with war veterans and recently traumatized children,adolescents,and adults having PTSD and use of animal models subjected to various stressors and the effects of suppressing or overexpressing specific microRNAs.